Of note, whereas EPO and TPO are low in MPNs, high levels of JAK2-activating G-CSF (and IL-6) were observed in MPN patients despite the fact that patients typically present with elevated neutrophil counts. The gene discussed is JAK2; the disease is myeloproliferative neoplasm.